X. Shao et al., COLORIMETRIC ASSAYS FOR EVALUATION OF THE MODE OF ACTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITORS, Antiviral chemistry & chemotherapy, 9(2), 1998, pp. 167-176
Four non-nucleoside reverse transcriptase (RT) inhibitors, 9-CI-TIBO r
ahydro-9-chloro-5-methyl-6-(3-methyl-2-butenyl)im 5,1-jk)(1,4)-benzodi
azepin-2(1H)-thione)], nevi rapine 11-cyclopropyl-4-methyl-dipyrido[2,
3-b:2',3'-e]-[1 ,4]diazepin-6-one), MSA-300 nyl)cyclopropyl]-N'-(5-chl
oropyrid-2-yl)-thiourea) and delavirdine ethanesulphonamido-1H-indol-2
-yl-carbonyl)-4-[3-(1 -methylethylamino)pyridinyl] piperazine) were an
alysed for the mode of action of their inhibition of human immuno-defi
ciency virus type 1 (HIV-1) RT in three different assays utilizing a 9
6-well microtitre plate format, with solid-phase conjugated poly(ra) a
s template. These were: (i) direct RT assay for determination of IC50
values of RT inhibitors; (ii) RT template/primer binding inhibition (B
IG) assay, for measuring the effect of various substances on the RT ac
tivity binding to template/primer; (iii) RT protein ELISA, for measuri
ng RT protein binding to template/primer with a monoclonal antibody re
active against a peptide in the RNase H region. MSA-300 and delavirdin
e gave the lowest IC50 values, ranging from 0.17 mu M to 0.24 mu M for
MSA-300 and from 0.12 mu M to 0.38 mu M for delavirdine, whereas high
er IC50 values of approximately 20 mu M were obtained for 9-CI-TIBO at
all primer concentrations. None of the non-nucleoside substances had
inhibiting effects on the binding of template, primer, or template/pri
mer to RT protein. Their inhibition of RT activity was not due to prev
ention of RT binding to template/primer. TIBO, nevirapine and delavird
ine bound to RT reversibly and they bound more tightly to RT template/
primer ternary than to RT template binary complex. MSA-300 showed a co
mparatively high affinity for the enzyme. The utility of the three ass
ays in relation to screening and analysis of RT inhibitory substances
is discussed.